ACBM
ACRO BIOMEDICAL CO., LTD.Company Information
- Company Name
- ACRO BIOMEDICAL CO., LTD.
- CIK
- CIK0001622996
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ACBM: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 07 Trade & Services
- SIC
- 7900
- SIC Description
- Services-Amusement & Recreation Services
- Ticker
- ACBM
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Security Deposit | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | ||||||
| Retained Earnings Accumulated Deficit | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | ||||||
| Deferred Compensation Equity | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | ||||||
| Shares Outstanding | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialACRO BIOMEDICAL CO., LTD. (ACBM) — SEC Financial Statements & Analysis
ACRO BIOMEDICAL CO., LTD. (ACBM) is a services-amusement & recreation services company, incorporated in NV. ACRO BIOMEDICAL CO., LTD. trades on OTC as: ACBM. ACRO BIOMEDICAL CO., LTD. (ACBM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, ACRO BIOMEDICAL CO., LTD. carries a market cap of $1.56M, a P/E ratio of -11.12x, a P/B ratio of -3.51x, a P/S ratio of 250.18x, an enterprise value of $1.56M, and an EV/EBITDA multiple of -7.44x. On profitability, it posts an operating margin of -3533.57%, a net margin of -3534.45%, a Return on Equity (ROE) of 36.84%, and a Return on Assets (ROA) of -493.33%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 200.25% year-over-year, and EPS growth of 200.25% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.01x, working capital of $-444.79K, a debt-to-equity ratio of -1.01x, a debt ratio of 122.93, free cash flow of $-140.11K (TTM), and net debt of $-3.65K. Figures sourced from SEC EDGAR.
- Market Cap
- $1.56M
- P/E TTM
- -11.12x
- EPS TTM
- $-0.00
- P/B TTM
- -3.51x
- ROE TTM
- 36.84%
- ROA TTM
- -493.33%
- Debt To Equity
- -1.01x
- Free Cash Flow TTM
- $-140.11K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ACRO BIOMEDICAL CO., LTD. in?
ACRO BIOMEDICAL CO., LTD. (ACBM) operates in the Services-Amusement & Recreation Services industry.
What exchange does ACBM trade on?
ACRO BIOMEDICAL CO., LTD. (ACBM) trades on the OTC.
Where is ACRO BIOMEDICAL CO., LTD. incorporated?
ACRO BIOMEDICAL CO., LTD. is incorporated in NV.
When was ACRO BIOMEDICAL CO., LTD. (ACBM)'s most recent SEC filing?
ACRO BIOMEDICAL CO., LTD. (ACBM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ACBM's market cap?
ACRO BIOMEDICAL CO., LTD. (ACBM) has a market capitalization of $1.56M as of 2026-06-30.
What is ACBM's EPS (earnings per share)?
ACRO BIOMEDICAL CO., LTD. (ACBM)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is ACBM's ROE (return on equity)?
ACRO BIOMEDICAL CO., LTD. (ACBM)'s trailing twelve month Return on Equity (ROE) is 36.84% as of 2026-06-30.
What is ACBM's ROA (return on assets)?
ACRO BIOMEDICAL CO., LTD. (ACBM)'s trailing twelve month Return on Assets (ROA) is -493.33% as of 2026-06-30.
What is ACBM's EV/EBITDA?
ACRO BIOMEDICAL CO., LTD. (ACBM)'s trailing twelve month EV/EBITDA is -7.44x as of 2026-06-30.